000 02119 a2200613 4500
005 20250513124900.0
264 0 _c19971208
008 199712s 0 0 eng d
022 _a0021-9738
024 7 _a10.1172/JCI119675
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTerzi, F
245 0 0 _aReduction of renal mass is lethal in mice lacking vimentin. Role of endothelin-nitric oxide imbalance.
_h[electronic resource]
260 _bThe Journal of clinical investigation
_cSep 1997
300 _a1520-8 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAcetylcholine
_xpharmacology
650 0 4 _aAnimals
650 0 4 _aAntihypertensive Agents
_xpharmacology
650 0 4 _aBlotting, Northern
650 0 4 _aBosentan
650 0 4 _aCreatinine
_xblood
650 0 4 _aEndothelin Receptor Antagonists
650 0 4 _aEndothelin-1
_xmetabolism
650 0 4 _aEnzyme Inhibitors
_xpharmacology
650 0 4 _aImmunohistochemistry
650 0 4 _aIn Vitro Techniques
650 0 4 _aIndomethacin
_xpharmacology
650 0 4 _aKidney
_xblood supply
650 0 4 _aMice
650 0 4 _aMice, Knockout
650 0 4 _aMice, Mutant Strains
650 0 4 _aMuscle, Smooth, Vascular
_xdrug effects
650 0 4 _aNADPH Dehydrogenase
_xmetabolism
650 0 4 _aNephrectomy
_xmethods
650 0 4 _aNitric Oxide
_xphysiology
650 0 4 _aNitroarginine
_xpharmacology
650 0 4 _aNitroprusside
_xpharmacology
650 0 4 _aPhorbol 12,13-Dibutyrate
_xpharmacology
650 0 4 _aRNA, Messenger
_xanalysis
650 0 4 _aSulfonamides
_xpharmacology
650 0 4 _aVasoconstrictor Agents
_xpharmacology
650 0 4 _aVasodilator Agents
_xpharmacology
650 0 4 _aVimentin
_xdeficiency
700 1 _aHenrion, D
700 1 _aColucci-Guyon, E
700 1 _aFederici, P
700 1 _aBabinet, C
700 1 _aLevy, B I
700 1 _aBriand, P
700 1 _aFriedlander, G
773 0 _tThe Journal of clinical investigation
_gvol. 100
_gno. 6
_gp. 1520-8
856 4 0 _uhttps://doi.org/10.1172/JCI119675
_zAvailable from publisher's website
999 _c9272719
_d9272719